{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:46:00Z","timestamp":1790682360650,"version":"4.1.0"},"reference-count":79,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2016.00172","type":"journal-article","created":{"date-parts":[[2016,7,20]],"date-time":"2016-07-20T13:05:15Z","timestamp":1469019915000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":35,"title":["Bone Marrow Immunity and Myelodysplasia"],"prefix":"10.3389","volume":"6","author":[{"given":"Claude","family":"Lambert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuenv","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Aanei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,7,20]]},"reference":[{"issue":"2","key":"B1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.5045\/br.2015.50.2.73","article-title":"Apoptosis: role in myeloid cell development","volume":"50","author":"Sarvothaman","year":"2015","journal-title":"Blood Res"},{"issue":"2","key":"B2","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/leu.2014.325","article-title":"Myelodysplasia is in the niche: novel concepts and emerging therapies","volume":"29","author":"Bulycheva","year":"2014","journal-title":"Leukemia"},{"issue":"3","key":"B3","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.cell.2016.01.002","article-title":"Cancer immunosurveillance by tissue-resident innate lymphoid cells and innate-like T cells","volume":"164","author":"Dadi","year":"2016","journal-title":"Cell"},{"key":"B4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.coi.2015.11.001","article-title":"Immunosurveillance and immunotherapy of tumors by innate immune cells","volume":"38","author":"Iannello","year":"2016","journal-title":"Curr Opin Immunol"},{"issue":"3","key":"B5","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.exphem.2005.11.017","article-title":"CXCR4 and CCR5 mediate homing of primitive bone marrow-derived hematopoietic cells to the postnatal thymus","volume":"34","author":"Robertson","year":"2006","journal-title":"Exp Hematol"},{"issue":"6","key":"B6","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1182\/blood-2002-10-3293","article-title":"Involvement of CXCR4 and IL-2 in the homing and retention of human NK and NK T cells to the bone marrow and spleen of NOD\/SCID mice","volume":"102","author":"Beider","year":"2003","journal-title":"Blood"},{"issue":"11","key":"B7","doi-asserted-by":"publisher","first-page":"4595","DOI":"10.1172\/JCI67580","article-title":"Induction of myelodysplasia by myeloid-derived suppressor cells","volume":"123","author":"Chen","year":"2013","journal-title":"J Clin Invest"},{"issue":"8","key":"B8","doi-asserted-by":"publisher","first-page":"4499","DOI":"10.4049\/jimmunol.0802740","article-title":"Myeloid-derived suppressor cells: linking inflammation and cancer","volume":"182","author":"Ostrand-Rosenberg","year":"2009","journal-title":"J Immunol"},{"issue":"12","key":"B9","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.3109\/10428194.2014.904511","article-title":"Myeloid derived suppressor cells are numerically, functionally and phenotypically different in patients with multiple myeloma","volume":"55","author":"Favaloro","year":"2014","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"B10","doi-asserted-by":"publisher","first-page":"3815","DOI":"10.4049\/jimmunol.1203373","article-title":"Myeloid-derived suppressor cells regulate growth of multiple myeloma by inhibiting T cells in bone marrow","volume":"190","author":"Ramachandran","year":"2013","journal-title":"J Immunol"},{"issue":"15","key":"B11","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1182\/blood-2012-08-448548","article-title":"Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans","volume":"121","author":"Gorgun","year":"2013","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3389\/fonc.2014.00349","article-title":"Myeloid-derived suppressor cells as therapeutic target in hematological malignancies","volume":"4","author":"De Veirman","year":"2014","journal-title":"Front Oncol"},{"issue":"1","key":"B13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12185-011-1001-x","article-title":"Myelodysplastic syndromes: revisiting the role of the bone marrow microenvironment in disease pathogenesis","volume":"95","author":"Raaijmakers","year":"2012","journal-title":"Int J Hematol"},{"issue":"6","key":"B14","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s12185-014-1583-1","article-title":"Regulation of hematopoiesis in endosteal microenvironments","volume":"99","author":"Asada","year":"2014","journal-title":"Int J Hematol"},{"issue":"4","key":"B15","doi-asserted-by":"publisher","first-page":"310","DOI":"10.2174\/157339409789712681","article-title":"Myeloid malignancies and the marrow microenvironment: some recent studies in patients with MDS","volume":"5","author":"Marcondes","year":"2009","journal-title":"Curr Cancer Ther Rev"},{"issue":"8","key":"B16","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1073\/pnas.1222861110","article-title":"Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes","volume":"110","author":"Pang","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"B17","doi-asserted-by":"publisher","first-page":"339","DOI":"10.5507\/bp.2013.084","article-title":"Molecular genetic methods in the diagnosis of myelodysplastic syndromes. A review","volume":"158","author":"Lukackova","year":"2014","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"issue":"18","key":"B18","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1016\/j.yexcr.2011.08.007","article-title":"Focal adhesion protein abnormalities in myelodysplastic mesenchymal stromal cells","volume":"317","author":"Aanei","year":"2011","journal-title":"Exp Cell Res"},{"issue":"7","key":"B19","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/S0145-2126(01)00193-X","article-title":"In vitro characterization of hematopoietic microenvironment cells from patients with myelodysplastic syndrome","volume":"26","author":"Flores-Figueroa","year":"2002","journal-title":"Leuk Res"},{"issue":"2","key":"B20","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/stem.787","article-title":"Bone marrow-derived mesenchymal stromal cells are attracted by multiple myeloma cell-produced chemokine CCL25 and favor myeloma cell growth in vitro and in vivo","volume":"30","author":"Xu","year":"2012","journal-title":"Stem Cells"},{"issue":"5","key":"B21","first-page":"606","article-title":"Effects of recombinant human granulocyte colony-stimulating factor administration on neutrophil phenotype and functions","volume":"82","author":"Carulli","year":"1997","journal-title":"Haematologica"},{"issue":"4","key":"B22","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/j.1365-2141.1991.tb08619.x","article-title":"Interleukin-6 and interleukin-1 enhancement of GM-CSF-dependent proliferation of haematopoietic progenitor cells in myelodysplastic syndromes","volume":"77","author":"Schipperus","year":"1991","journal-title":"Br J Haematol"},{"issue":"12","key":"B23","first-page":"1268","article-title":"Measurement of serum cytokine levels in patients with myelodysplastic syndromes","volume":"6","author":"Verhoef","year":"1992","journal-title":"Leukemia"},{"issue":"2","key":"B24","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/BF02989591","article-title":"Serum transforming growth factor-beta 1 is related to the degree of immunoparesis in patients with multiple myeloma","volume":"15","author":"Kyrtsonis","year":"1998","journal-title":"Med Oncol"},{"issue":"6B","key":"B25","first-page":"5323","article-title":"Measurement of mRNA expression for a variety of cytokines and its receptors in bone marrows of patients with myelodysplastic syndromes","volume":"19","author":"Allampallam","year":"1999","journal-title":"Anticancer Res"},{"issue":"1","key":"B26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/BF03032653","article-title":"Detection of TNFalpha expression in the bone marrow and determination of TNFalpha production of peripheral blood mononuclear cells in myelodysplastic syndrome","volume":"6","author":"Molnar","year":"2000","journal-title":"Pathol Oncol Res"},{"issue":"1","key":"B27","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1365-2141.2009.07593.x","article-title":"IL-17-producing CD4(+) T cells, pro-inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome","volume":"145","author":"Kordasti","year":"2009","journal-title":"Br J Haematol"},{"issue":"5","key":"B28","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1053\/j.seminoncol.2011.04.006","article-title":"Immunologic aspects of hypoplastic myelodysplastic syndrome","volume":"38","author":"Calado","year":"2011","journal-title":"Semin Oncol"},{"issue":"5","key":"B29","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.stem.2012.03.007","article-title":"Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-\/FAS-mediated T cell apoptosis","volume":"10","author":"Akiyama","year":"2012","journal-title":"Cell Stem Cell"},{"issue":"12","key":"B30","doi-asserted-by":"publisher","first-page":"e51339","DOI":"10.1371\/journal.pone.0051339","article-title":"Th22 cells as well as Th17 cells expand differentially in patients with early-stage and late-stage myelodysplastic syndrome","volume":"7","author":"Shao","year":"2012","journal-title":"PLoS One"},{"key":"B31","first-page":"31","article-title":"Immunological derangement in hypocellular myelodysplastic syndromes","volume":"8","author":"Serio","year":"2014","journal-title":"Transl Med UniSa"},{"issue":"1","key":"B32","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.bbcan.2014.04.003","article-title":"Signaling pathways involved in MDSC regulation","volume":"1846","author":"Trikha","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"B33","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1046\/j.0007-1048.2002.03366.x","article-title":"Excessive apoptosis, increased phagocytosis, nuclear inclusion bodies and cylindrical confronting cisternae in bone marrow biopsies of myelodysplastic syndrome patients","volume":"116","author":"Shetty","year":"2002","journal-title":"Br J Haematol"},{"issue":"8","key":"B34","doi-asserted-by":"publisher","first-page":"4717","DOI":"10.4049\/jimmunol.172.8.4717","article-title":"Macrophages and stromal cells phagocytose apoptotic bone marrow-derived B lineage cells","volume":"172","author":"Dogusan","year":"2004","journal-title":"J Immunol"},{"issue":"8","key":"B35","doi-asserted-by":"publisher","first-page":"e71120","DOI":"10.1371\/journal.pone.0071120","article-title":"Overexpression of the toll-like receptor (TLR) signaling adaptor MYD88, but lack of genetic mutation, in myelodysplastic syndromes","volume":"8","author":"Dimicoli","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"B36","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.3324\/haematol.2012.064642","article-title":"Impaired clearance of apoptotic cells leads to HMGB1 release in the bone marrow of patients with myelodysplastic syndromes and induces TLR4-mediated cytokine production","volume":"98","author":"Velegraki","year":"2013","journal-title":"Haematologica"},{"issue":"9","key":"B37","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1038\/leu.2013.180","article-title":"Toll-like receptor alterations in myelodysplastic syndrome","volume":"27","author":"Wei","year":"2013","journal-title":"Leukemia"},{"issue":"10","key":"B38","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1084\/jem.20080132","article-title":"Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein","volume":"205","author":"Cheng","year":"2008","journal-title":"J Exp Med"},{"issue":"3","key":"B39","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/BF02887733","article-title":"Immunohistochemical study of T lymphocyte subsets on frozen substituted plastic embedding section of the bone marrow from patients with myelodysplastic syndrome and its clinical implication","volume":"19","author":"Liu","year":"1999","journal-title":"J Tongji Med Univ"},{"issue":"9","key":"B40","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1002\/cncr.10915","article-title":"Effects of cyclosporine on hematopoietic and immune functions in patients with hypoplastic myelodysplasia: in vitro and in vivo studies","volume":"95","author":"Selleri","year":"2002","journal-title":"Cancer"},{"issue":"4","key":"B41","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1053\/j.semdp.2011.08.005","article-title":"Myelodysplastic syndromes","volume":"28","author":"Zhou","year":"2011","journal-title":"Semin Diagn Pathol"},{"issue":"10","key":"B42","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1007\/s12094-010-0574-9","article-title":"Myelodysplastic syndromes: an update on molecular pathology","volume":"12","author":"Tormo","year":"2010","journal-title":"Clin Transl Oncol"},{"issue":"11","key":"B43","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/S0301-472X(01)00736-6","article-title":"Increased cytotoxic T cells with effector phenotype in aplastic anemia and myelodysplasia","volume":"29","author":"Kook","year":"2001","journal-title":"Exp Hematol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21349","article-title":"Natural killer cell (NK) subsets and NK-like T-cell populations in acute myeloid leukemias and myelodysplastic syndromes","author":"Aggarwal","year":"2016","journal-title":"Cytometry B Clin Cytom"},{"issue":"4","key":"B45","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3324\/haematol.13612","article-title":"Immune mediated autologous cytotoxicity against hematopoietic precursor cells in patients with myelodysplastic syndrome","volume":"94","author":"Chamuleau","year":"2009","journal-title":"Haematologica"},{"issue":"1","key":"B46","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1053\/j.seminhematol.2007.11.006","article-title":"The role of the immune system in myelodysplasia: implications for therapy","volume":"45","author":"Sloand","year":"2008","journal-title":"Semin Hematol"},{"issue":"1","key":"B47","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1365-2141.2009.07921.x","article-title":"Immune dysregulation and dyserythropoiesis in the myelodysplastic syndromes","volume":"148","author":"Alfinito","year":"2010","journal-title":"Br J Haematol"},{"issue":"4","key":"B48","doi-asserted-by":"publisher","first-page":"602","DOI":"10.3324\/haematol.2010.030536","article-title":"Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes","volume":"96","author":"Feng","year":"2011","journal-title":"Haematologica"},{"issue":"20","key":"B49","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1182\/blood-2010-01-262071","article-title":"Recurrent expression signatures of cytokines and chemokines are present and are independently prognostic in acute myelogenous leukemia and myelodysplasia","volume":"116","author":"Kornblau","year":"2010","journal-title":"Blood"},{"issue":"11","key":"B50","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1038\/sj.leu.2404868","article-title":"Defects of immune surveillance offer new insights into the pathophysiology and therapy of myelodysplastic syndromes","volume":"21","author":"Kiladjian","year":"2007","journal-title":"Leukemia"},{"issue":"7","key":"B51","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.leukres.2007.10.004","article-title":"The clinical significance of activated lymphocytes in patients with myelodysplastic syndromes: a single centre study of 131 patients","volume":"32","author":"Meers","year":"2008","journal-title":"Leuk Res"},{"issue":"5","key":"B52","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3324\/haematol.2014.118679","article-title":"Impaired cytotoxicity associated with defective natural killer cell differentiation in myelodysplastic syndromes","volume":"100","author":"Hejazi","year":"2015","journal-title":"Haematologica"},{"issue":"1","key":"B53","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1365-2141.1995.tb03375.x","article-title":"Effects of interleukin-12 on natural killer cell cytotoxicity and the production of interferon-gamma and tumour necrosis factor-alpha in patients with myelodysplastic syndromes","volume":"90","author":"Ogata","year":"1995","journal-title":"Br J Haematol"},{"issue":"3","key":"B54","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1046\/j.1365-2141.2002.03875.x","article-title":"Selective reduction of natural killer T cells in the bone marrow of aplastic anaemia","volume":"119","author":"Zeng","year":"2002","journal-title":"Br J Haematol"},{"issue":"1\u20132","key":"B55","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s12026-012-8285-7","article-title":"Investigation of NK cell function and their modulation in different malignancies","volume":"52","author":"Konjevic","year":"2012","journal-title":"Immunol Res"},{"issue":"8","key":"B56","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1073\/pnas.0712391105","article-title":"Dysregulation of IL-32 in myelodysplastic syndrome and chronic myelomonocytic leukemia modulates apoptosis and impairs NK function","volume":"105","author":"Marcondes","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"B57","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/MOH.0b013e3283257ac7","article-title":"Advancements in the molecular pathogenesis of myelodysplastic syndrome","volume":"16","author":"Epling-Burnette","year":"2009","journal-title":"Curr Opin Hematol"},{"issue":"19","key":"B58","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1182\/blood-2013-10-533398","article-title":"CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets","volume":"123","author":"Gleason","year":"2014","journal-title":"Blood"},{"issue":"4","key":"B59","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1046\/j.1365-2141.2003.04465.x","article-title":"Severe and selective deficiency of interferon-gamma-producing invariant natural killer T cells in patients with myelodysplastic syndromes","volume":"122","author":"Fujii","year":"2003","journal-title":"Br J Haematol"},{"issue":"3","key":"B60","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.clim.2011.03.001","article-title":"Th17 and Foxp3(+) T regulatory cell dynamics and distribution in myelodysplastic syndromes","volume":"139","author":"Bouchliou","year":"2011","journal-title":"Clin Immunol"},{"issue":"2","key":"B61","doi-asserted-by":"publisher","first-page":"e22654","DOI":"10.4161\/onci.22654","article-title":"Effector memory regulatory T-cell expansion marks a pivotal point of immune escape in myelodysplastic syndromes","volume":"2","author":"Mailloux","year":"2013","journal-title":"Oncoimmunology"},{"issue":"8","key":"B62","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1182\/blood-2009-03-208629","article-title":"Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia","volume":"115","author":"Vinh","year":"2010","journal-title":"Blood"},{"issue":"6","key":"B63","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1182\/blood-2013-07-517151","article-title":"The evolution of cellular deficiency in GATA2 mutation","volume":"123","author":"Dickinson","year":"2014","journal-title":"Blood"},{"issue":"8","key":"B64","doi-asserted-by":"publisher","first-page":"795","DOI":"10.2169\/internalmedicine.40.795","article-title":"Myelodysplasia associated with acquired immunodeficiency syndrome","volume":"40","author":"Ryu","year":"2001","journal-title":"Intern Med"},{"issue":"4","key":"B65","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/j.1365-2141.2007.06923.x","article-title":"Tumour necrosis factor-induced gene expression in human marrow stroma: clues to the pathophysiology of MDS?","volume":"140","author":"Stirewalt","year":"2008","journal-title":"Br J Haematol"},{"issue":"11","key":"B66","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/j.exphem.2007.09.007","article-title":"Apoptosis and antiapoptotic mechanisms in the progression of myelodysplastic syndrome","volume":"35","author":"Kerbauy","year":"2007","journal-title":"Exp Hematol"},{"issue":"1","key":"B67","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.canlet.2004.05.011","article-title":"Modulation of TNF-alpha activity in tumor PC cells using anti-CD45 and anti-CD95 monoclonal antibodies","volume":"214","author":"Jurisic","year":"2004","journal-title":"Cancer Lett"},{"issue":"2","key":"B68","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s00277-005-0010-3","article-title":"Effect of TNF-alpha on Raji cells at different cellular levels estimated by various methods","volume":"85","author":"Jurisic","year":"2006","journal-title":"Ann Hematol"},{"issue":"2","key":"B69","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/cyto.a.20512","article-title":"Myelodysplasia and anemia of chronic disease in human tumor necrosis factor-alpha transgenic mice","volume":"73","author":"Capocasale","year":"2008","journal-title":"Cytometry A"},{"issue":"9","key":"B70","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1038\/sj.leu.2403875","article-title":"Involvement of transforming growth factor-beta and thrombopoietin in the pathogenesis of myelodysplastic syndrome with myelofibrosis","volume":"19","author":"Akiyama","year":"2005","journal-title":"Leukemia"},{"key":"B71","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1186\/1755-1536-5-S1-S21","article-title":"Myelofibrosis: molecular and cell biological aspects. (Suppl 1 Proceedings of fibroproliferative disorders: from biochemical analysis to targeted therapies, Petro E. Petrides and David Brenner)","volume":"5","author":"Kreipe","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"10","key":"B72","doi-asserted-by":"publisher","first-page":"5065","DOI":"10.4049\/jimmunol.1202775","article-title":"Mesenchymal stem cells tune the development of monocyte-derived dendritic cells toward a myeloid-derived suppressive phenotype through growth-regulated oncogene chemokines","volume":"190","author":"Chen","year":"2013","journal-title":"J Immunol"},{"issue":"10","key":"B73","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1136\/jcp.36.10.1120","article-title":"Defective neutrophil function and microbicidal mechanisms in the myelodysplastic disorders","volume":"36","author":"Martin","year":"1983","journal-title":"J Clin Pathol"},{"issue":"5","key":"B74","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/ejh.12443","article-title":"The myelodysplastic syndromes: the era of understanding","volume":"94","author":"Meers","year":"2015","journal-title":"Eur J Haematol"},{"issue":"9","key":"B75","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1182\/blood-2005-04-1543","article-title":"Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndrome","volume":"106","author":"Sternberg","year":"2005","journal-title":"Blood"},{"issue":"3","key":"B76","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/ejh.12311","article-title":"Paraneoplastic inflammation in myelodysplastic syndrome or bone marrow failure: case series with focus on 5-azacytidine and literature review","volume":"93","author":"Frietsch","year":"2014","journal-title":"Eur J Haematol"},{"issue":"1","key":"B77","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3324\/haematol.10546","article-title":"Anti-erythroblast autoimmunity in early myelodysplastic syndromes","volume":"92","author":"Barcellini","year":"2007","journal-title":"Haematologica"},{"issue":"1","key":"B78","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.leukres.2014.11.008","article-title":"Aplastic anemia & MDS International Foundation (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2014","volume":"39","author":"Visconte","year":"2015","journal-title":"Leuk Res"},{"issue":"2","key":"B79","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1532\/IJH97.04149","article-title":"Hepatosplenic alphabeta T-cell lymphoma with myelodysplastic syndrome","volume":"82","author":"Takaku","year":"2005","journal-title":"Int J Hematol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"deposited":{"date-parts":[[2016,8,12]],"date-time":"2016-08-12T12:50:23Z","timestamp":1471006223000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fonc.2016.00172\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,20]]},"references-count":79,"URL":"https:\/\/doi.org\/10.3389\/fonc.2016.00172","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,20]]}}}